What is MediVis?
MediVis operates at the intersection of advanced technology and healthcare, developing sophisticated medical imaging and visualization solutions tailored for surgical environments. The company's technology aims to enhance surgical precision and patient outcomes by providing surgeons with real-time, detailed visual data during procedures. This focus positions MediVis as a key player in the rapidly evolving field of surgical technology and digital health.
How much funding has MediVis raised?
MediVis has raised a total of $20M across 1 funding round:
Series A
$20M
Series A (2023): $20M with participation from Initialized Capital, Mayo Clinic, and Thrive Capital
Key Investors in MediVis
Initialized Capital
Initialized Capital is a venture capital firm focused on early-stage founders across sectors like enterprise SaaS, health, and AI, providing essential tools and guidance for long-term success.
Mayo Clinic
Mayo Clinic is a global healthcare organization renowned for its integrated clinical practice, education, and medical research, contributing to medical advancement and healthcare innovation.
Thrive Capital
Thrive Capital is an investment venture capital company based in New York, specializing in internet and software investments.
What's next for MediVis?
The recent major strategic investment signals a pivotal phase for MediVis, likely enabling the company to accelerate product development, expand its market reach, and further integrate its visualization technologies into clinical workflows. This substantial backing from prominent investors suggests confidence in MediVis's potential to disrupt the surgical imaging market and improve healthcare delivery through technological innovation. The company is poised for significant scaling and further advancements in its offerings.
See full MediVis company page
